Vascular Therapies is a biotechnology company focused on improving patient outcomes by reducing surgical stenosis in patients with kidney and vascular disease. The company has developed Sirogen™, an investigational sirolimus formulation for local, perivascular drug delivery. Sirogen™ is currently undergoing clinical trials to determine its safety and effectiveness in improving vascular access outcomes in patients requiring an arteriovenous fistula for hemodialysis.
View Top Employees from Vascular Therapies| Website | http://www.vasculartx.com |
| Revenue | $3 million |
| Funding | $17.3 million |
| Employees | 8 (8 on RocketReach) |
| Founded | 2001 |
| Address | 105 Union Avenue, Cresskill, New Jersey 07626, US |
| Phone | (201) 266-8310 |
| Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Business Services General, Biotechnology, Business Services, Science and Engineering, Pharmaceutical, Health Care |
| Web Rank | 10 Million |
| Keywords | Vascular Therapies |
| SIC | SIC Code 80 Companies, SIC Code 809 Companies |
| NAICS | NAICS Code 62 Companies, NAICS Code 62149 Companies, NAICS Code 6214 Companies, NAICS Code 621 Companies, NAICS Code 621492 Companies |
Looking for a particular Vascular Therapies employee's phone or email?
Vascular Therapies Questions
The Vascular Therapies annual revenue was $3 million in 2024.
Rosanne Terraciano is the Vice President of Operations of Vascular Therapies.
8 people are employed at Vascular Therapies.
Vascular Therapies is based in Cresskill, New Jersey.
The NAICS codes for Vascular Therapies are [62, 62149, 6214, 621, 621492].
The SIC codes for Vascular Therapies are [80, 809].
Top Vascular Therapies Employees
-
45+
-
32
-
3
-
21
-
25+
-
ViewRon Eggan
Sr. Director of Manufacturing at Vascular Therapies
Doylestown, Pennsylvania, United States42 -
ViewDavid Kornhauser
Vice President of Regulatory Affairs at Vascular Therapies
Pompano Beach, FL, US24 -
53
Related Companies
